Cargando…
SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
In late 2019, the betacoronavirus SARS-CoV-2 was identified as the viral agent responsible for the coronavirus disease 2019 (COVID-19) pandemic. Coronaviruses Spike proteins are responsible for their ability to interact with host membrane receptors and different proteins have been identified as SARS...
Autores principales: | Fenizia, Claudio, Galbiati, Silvia, Vanetti, Claudia, Vago, Riccardo, Clerici, Mario, Tacchetti, Carlo, Daniele, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226513/ https://www.ncbi.nlm.nih.gov/pubmed/34201214 http://dx.doi.org/10.3390/cells10061434 |
Ejemplares similares
-
Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants
por: Fenizia, Claudio, et al.
Publicado: (2022) -
Effect of SARS-CoV-2 infection in pregnancy on CD147, ACE2 and HLA-G expression
por: Schiuma, Giovanna, et al.
Publicado: (2023) -
ACE2: At the crossroad of COVID-19 and lung cancer
por: Gottschalk, Gunnar, et al.
Publicado: (2021) -
CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and metabolic reprogramming
por: Kendrick, Agnieszka A., et al.
Publicado: (2016) -
SARS-CoV-2 host receptors ACE2 and CD147 (BSG) are present on human oocytes and blastocysts
por: Essahib, Wafaa, et al.
Publicado: (2020)